244 related articles for article (PubMed ID: 18991891)
21. Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies.
García-Gutiérrez MS; Navarrete F; Gasparyan A; Navarro D; Morcuende Á; Femenía T; Manzanares J
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682586
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference.
Liu QR; Canseco-Alba A; Zhang HY; Tagliaferro P; Chung M; Dennis E; Sanabria B; Schanz N; Escosteguy-Neto JC; Ishiguro H; Lin Z; Sgro S; Leonard CM; Santos-Junior JG; Gardner EL; Egan JM; Lee JW; Xi ZX; Onaivi ES
Sci Rep; 2017 Dec; 7(1):17410. PubMed ID: 29234141
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.
Xu JJ; Diaz P; Astruc-Diaz F; Craig S; Munoz E; Naguib M
Anesth Analg; 2010 Jul; 111(1):99-109. PubMed ID: 20522703
[TBL] [Abstract][Full Text] [Related]
24. Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor.
Carrasquer A; Nebane NM; Williams WM; Song ZH
Pharmacogenet Genomics; 2010 Mar; 20(3):157-66. PubMed ID: 20124950
[TBL] [Abstract][Full Text] [Related]
25. A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands.
Ishiguro H; Carpio O; Horiuchi Y; Shu A; Higuchi S; Schanz N; Benno R; Arinami T; Onaivi ES
Synapse; 2010 Jan; 64(1):92-6. PubMed ID: 19768813
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
Schmidt W; Schäfer F; Striggow V; Fröhlich K; Striggow F
Neuroscience; 2012 Dec; 227():313-26. PubMed ID: 23069763
[TBL] [Abstract][Full Text] [Related]
27. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [
Meletta R; Slavik R; Mu L; Rancic Z; Borel N; Schibli R; Ametamey SM; Krämer SD; Müller Herde A
Nucl Med Biol; 2017 Apr; 47():31-43. PubMed ID: 28104528
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.
Valenzano KJ; Tafesse L; Lee G; Harrison JE; Boulet JM; Gottshall SL; Mark L; Pearson MS; Miller W; Shan S; Rabadi L; Rotshteyn Y; Chaffer SM; Turchin PI; Elsemore DA; Toth M; Koetzner L; Whiteside GT
Neuropharmacology; 2005 Apr; 48(5):658-72. PubMed ID: 15814101
[TBL] [Abstract][Full Text] [Related]
30. Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption.
Pradier B; Erxlebe E; Markert A; Rácz I
Behav Brain Res; 2015; 287():163-71. PubMed ID: 25827923
[TBL] [Abstract][Full Text] [Related]
31. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR
Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280
[TBL] [Abstract][Full Text] [Related]
32. G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors.
Franklin JM; Carrasco GA
J Biol Chem; 2013 May; 288(22):15712-24. PubMed ID: 23592773
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid CB
Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX
Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215
[TBL] [Abstract][Full Text] [Related]
34. Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice.
Zoppi S; Madrigal JL; Caso JR; García-Gutiérrez MS; Manzanares J; Leza JC; García-Bueno B
Br J Pharmacol; 2014 Jun; 171(11):2814-26. PubMed ID: 24467609
[TBL] [Abstract][Full Text] [Related]
35. Increasing CB2 Receptor Activity after Early Life Stress Prevents Depressive Behavior in Female Rats.
Andersen SL
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672480
[TBL] [Abstract][Full Text] [Related]
36. Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS.
Onaivi ES
Curr Neuropharmacol; 2011 Mar; 9(1):205-8. PubMed ID: 21886591
[TBL] [Abstract][Full Text] [Related]
37. Opposing roles of CB
Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
[TBL] [Abstract][Full Text] [Related]
38. Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate.
La Porta C; Bura SA; Aracil-Fernández A; Manzanares J; Maldonado R
Pain; 2013 Jan; 154(1):160-174. PubMed ID: 23199705
[TBL] [Abstract][Full Text] [Related]
39. CB
Zhang HY; Shen H; Jordan CJ; Liu QR; Gardner EL; Bonci A; Xi ZX
Acta Pharmacol Sin; 2019 Mar; 40(3):398-409. PubMed ID: 29967455
[TBL] [Abstract][Full Text] [Related]
40. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
